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Abstract 12 
Chemical derivatives of  aArtemisinin, a sesquiterpene lactone produced by Artemisia annua, is 13 
are the active ingredient in the most effective treatment for malaria. Comprehensive 14 
phytochemical analysis of two contrasting chemotypes of A. annua resulted in the 15 
characterisation of over 80 natural products by NMR, more than 20 of which are novel and 16 
described here for the first time. Analysis of high- and low-artemisinin producing (HAP and 17 
LAP) chemotypes of A. annua confirmed the latter to have a low level of DBR2 (artemisinic 18 
DOGHK\GHǻ11 (13) reductase) gene expression. Here we show that the LAP chemotype accumulates 19 
high levels of artemisinic acid, arteannuin B, epi-deoxyarteannuin B and other amorpha-4,11-20 
diene derived sesquiterpenes which are unsaturated at the 11,13-position. By contrast, the HAP 21 
chemotype is rich in sesquiterpenes saturated at the 11,13-position (dihydroartemisinic acid, 22 
artemisinin and dihydro-epi-deoxyarteannunin B), which is consistent with higher expression 23 
levels of DBR2, and also with the presence of a HAP-chemotype version of CYP71AV1 24 
(amorpha-4,11-diene C-12 oxidase). Our results indicate that the conversion steps from 25 
artemisinic acid to arteannuin B, epi-deoxyarteannuin B and artemisitene in the LAP chemotype 26 
are non-enzymatic and parallel the non-enzymatic conversion of DHAA to artemisinin and 27 
dihyro-epi-deoxyarteannuin B in the HAP chemotype. Interestingly, artemisinic acid in the LAP 28 
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chemotype preferentially converts to arteannuin B rather than the endoperoxide bridge 29 
containing artemisitene. In contrast, in the HAP chemotype, DHAA preferentially converts to 30 
artemisinin. Broader metabolomic and transcriptomic profiling revealed significantly different 31 
terpenoid profiles and related terpenoid gene expression in these two morphologically distinct 32 
chemotypes. 33 
1 Introduction  34 
The Chemical derivatives of the sesquiterpene lactone, artemisinin, such as: artesunate, 35 
artemether or dihydroartemisinin  is are the one of several active ingredients in artemisinin-36 
combination therapies (ACTs) - the most effective treatment for malaria currently available. 37 
Biosynthesis of artemisinin occurs in specialized 10-celled biseriate glandular trichomes present 38 
on the leaves, stems and inflorescences of Artemisia annua (Duke and Paul, 1993; Duke et al., 39 
1994; Ferreira and Janick, 1995). Concentrations of artemisinin can range from 0.01% to 1.4% of 40 
leaf dry weight (Larson et al., 2013). The biosynthetic pathway from artemisinin precursors has 41 
been fully elucidated over the past decade (Figure 1 C). It starts from the cyclization of farnesyl 42 
pyrophosphate (FPP) to amorpha-4,11-diene (A-4,11-D) by amorph-4,11-diene synthase (AMS) 43 
(Bouwmeester et al., 1999; Mercke et al., 2000) followed by the three-step oxidation of A-4,11-44 
D by amorpha-4,11-diene C-12 oxidase (CYP71AV1), to artemisinic alcohol (AAOH), 45 
artemisinic aldehyde (AAA), and artemisinic acid (AA) (Ro et al., 2006; Teoh et al., 2006). 46 
ADH1 ± NAD-dependent alcohol dehydrogenase with specificity towards artemisinic alcohol 47 
plays a role in the formation of artemisinic aldehyde in the artemisinin pathway of A. annua 48 
(Paddon et al., 2013). The ADH1 gene has been used to improve yields of artemisinic acid 49 
production in yeast. (Paddon et al., 2013). ArtemisLQLF DOGHK\GH ǻ UHGXFWDVH (DBR2) 50 
catalyzes the formation of dihydroartemisinic aldehyde (DHAAA) from AAA (Zhang et al., 51 
2008). DHAAA is subsequently oxidized in the final enzymatic reaction to dihydroartemisinic 52 
acid (DHAA) by alcohol aldehyde dehydrogenase ALDH1 (Teoh et al., 2009; Zhang et al., 53 
2009). (Paddon et al., 2013)Genes encoding all of these biosynthetic enzymes have been shown 54 
to be highly expressed in apical and sub-apical cells of A. annua glandular trichomes (Olsson et 55 
al., 2009; Soetaert et al., 2013). Recent studies have revealed that the conversion of DHAA to 56 
artemisinin and dihydro-epi-deoxyarteannuin B (DHEDB) proceeds via a series of non-57 
enzymatic and spontaneous photochemical reactions, involving the highly reactive tertiary allylic 58 
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hydroperoxide of dihydroartemisinic acid, DHAAOOH (Wallaart et al., 1999; Sy and Brown, 59 
2002; Brown and Sy, 2004). Similarly, it has previously been proposed that AA is 60 
photochemically converted to arteannuin B (ArtB) via the tertiary allylic hydroperoxide of 61 
artemisinic acid (Brown and Sy, 2007).  62 
Based on the content of artemisinin and its precursors, two contrasting chemotypes of A. annua 63 
have been described: a low-artemisinin production (LAP) chemotype and a high-artemisinin 64 
production (HAP) chemotype (Wallaart et al., 2000). Both chemotypes contain artemisinin, but 65 
the HAP chemotype has a relatively high content of DHAA and artemisinin, whereas the LAP 66 
chemotype has a high content of AA and ArtB (Lomenn et al., 2006; Aresenault et al., 2006, 67 
(Larson et al., 2013). Recent studies have concluded that a major factor in determining the 68 
biochemical phenotype of HAPs and LAPs is the differential expression of DBR2 - with low 69 
expression in LAP chemotypes correlating with a number of insertions/deletions in the DBR2 70 
promoter sequence (Yang et al., 2015). We have recently shown that the overall pathway to 71 
artemisinin biosynthesis is under strict developmental control with early steps in the pathway 72 
occurring in young leaves and later steps in mature leaves (Czechowski et al., 2016). In the 73 
present study, we have used both metabolomics and transcriptomics to investigate the 74 
developmental regulation of sesquiterpene biosynthesis in HAP and LAP chemotypes. Using a 75 
combination of NMR and UPLC-/GC-MS techniques we have characterised a number of 76 
amorphane and cadinane sesquiterpenes in addition to other terpenes isolated from leaf glandular 77 
trichomes. We have also extended the transcript analysis in HAPs and LAPs beyond the genes 78 
encoding artemisinin-pathway enzymes. Our findings suggest profound differences in general 79 
terpenoid metabolism between HAP and LAP chemotypes that extend well beyond altered DBR2 80 
expression and artemisinin content. 81 
2. Materials and methods 82 
2.1 Plant material 83 
Artemis is an F1 hybrid variety of A. annua developed by Mediplant (Conthey, Switzerland), 84 
produced by crossing C4 and C1 parental material of East Asian origin (Delabays et al., 2001). 85 
Artemisinin content has been reported to reach 1.4% of the leaf dry weight when grown in the 86 
field, and its metabolite profile is typical for the HAP chemotype (Larson et al., 2013). NCV 87 
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³QRQ-FRPPHUFLDOYDULHW\´DQ³RSHQ-SROOLQDWHG´YDULHW\RI(XURSHDQRULJLQwas also provided 88 
by Mediplant, and has the lowest reported artemisinin content from any A. annua germplasm in 89 
addition to a metabolite profile characteristic of the LAP chemotype (Larson et al., 2013). Plants 90 
were grown from seeds in glasshouse conditions as previously described (Graham et al., 2010). 91 
2.2 Leaf area measurements 92 
The leaf area of glasshouse-grown plants was measured by scanning for leaves 14-16 (counting 93 
from the apical meristem), followed by calculation of the leaf area using LAMINA software 94 
(Bylesjo et al., 2008) 95 
2.3 Trichome density measurements  96 
Trichome density was quantified on the abaxial surface of the terminal leaflets of leaves 14-16 97 
(counting from the apical meristem). Trichomes were visualised using a Zeiss fluorescent 98 
dissecting microscope (fitted with a 470/40nm excitation filter/ 525/50nm emission filter). 99 
Images were recorded using AxioVision 4.7 software (Carl Zeiss Ltd. Herts., UK). Trichome 100 
number was counted manually across a 3 x 0.5 mm2 leaflet sample area and the average (mean) 101 
trichome density was then calculated for the whole leaf. 102 
 2.4 NMR structural data for natural compounds from Artemis and NCV.  103 
Leaf and stem material from Artemis (5 Kg) was extracted in CHCl3 (20 L). The organic solvent 104 
was removed by rotary evaporation and a portion of the residual dark green aromatic plant 105 
extract (ca 2.5 ZZ ZDV ³GU\-ORDGHG´ RQ WR D VLOLFD FROXPQ IRU JUDGLHQW FROXPQ106 
chromatography (see Table 2.4.1). 107 
2.4.1 Gradient Column Chromatography of the Artemis variety of A. annua 108 
Solvent Fraction 
10% EtOAc/hexane A, B*, C and D* 
20% EtOAc/hexane E, F, G, H, I* and J 
30% EtOAc/hexane K, L, M, N and O* 
50% EtOAc/hexane P and Q 
EtOAc R, S, T*, U and V 
Methanol W, X and Y 
 109 
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Each of the fractions A-Y from gradient column chromatography of Artemis were then further 110 
purified by isocratic preparative normal-phase HPLC (*fractions B, D, I, O and T were also 111 
subjected to a second round of isocratic column chromatography prior to prep. HPLC); and 112 
individual metabolites were then characterized by NMR, as listed in Fig. 1A and the 113 
Supplemental Table 1 (1D- and 2D-NMR data for all metabolites which are novel as natural 114 
products is also given in the Supplementary Section). Selected fractions were analysed by 115 
UPLC-APCI-high resolution MS to verify molecular weights and chemical formulae. Confirmed 116 
annotations were used to update m/z and retention time reference data, to enable reporting of 117 
these compounds from plant extracts by UPLC-MS. 118 
Leaf and stem material from the NCV variety of A. annua (780 g) was extracted in CHCl3 (4 L). 119 
The organic solvent was then removed by rotary evaporation and the residual dark green 120 
aromatic plant extract (16.6 g; ca 2% w/w) was dry-loaded onto a silica column for gradient 121 
column chromatography (see Table 2.4.2). 122 
2.4.2 Gradient Column Chromatography of the NCV variety of A. annua 123 
Solvent Fraction 
2% EtOAc/hexane A, B and C 
10% EtOAc/hexane D, E, F and G 
20% EtOAc/hexane G, H and I 
40% EtOAc/hexane J, K and L 
EtOAc M and N 
Methanol N 
Each of the fractions A-N from gradient column chromatography of NCV were then further 124 
purified by isocratic preparative normal-phase HPLC; individual metabolites were then 125 
characterized by NMR, as listed in Fig. 1B and the Supplemental Table 1 (1D- and 2D-NMR 126 
data for all metabolites which are novel as natural products are also given in the Supplementary 127 
Section). Selected fractions were analysed by UPLC-APCI-high resolution MS to verify 128 
molecular weights and chemical formulae. Confirmed annotations were used to update m/z and 129 
retention time reference data, to enable reporting of these compounds from plant extracts by 130 
UPLC-MS. 131 
2.5 Metabolite analysis by UPLC-MS and GC-MS 132 
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Metabolite analysis by UPLC- and GC-MS were performed as described previously 133 
(Czechowski et al., 2016). Fifteen plants from each of five genotype classes were grown from 134 
seeds in 4-inch pots under 16 h days for 12 weeks. Metabolite profiles were generated from 50 135 
mg fresh weight (FW) pooled samples of leaves collected at two different developmental stages: 136 
1-5 (counted from the apical meristem), representing the juvenile stage; and leaves 11-13, 137 
representing the mature, expanded stage (Figure 1A). Fresh leaf samples were stored at -80°C, 138 
pending analysis. In addition, dry leaf material was also obtained from 14-week old plants, cut 139 
just above the zone of senescing leaves, and dried for 14 days at 40°C. Leaves were stripped 140 
from the plants, and leaf material sieved through 5 mm mesh to remove small stems. Trichome-141 
specific metabolites were extracted as described previously (Czechowski et al., 2016) with minor 142 
modifications. Briefly, 50 mg of fresh material was extracted by gentle shaking in 500 µ l 143 
chloroform for 1 h. Supernatant was taken out and remaining plant material was fully dried in a 144 
centrifugal evaporator (GeneVac® Ez-2 plus, Genevac Ltd, Ipswich, UK). Weight of the 145 
extracted and dried material was taken and used to quantify abundance of the specific 146 
compounds per unit of extracted dry weight.  Dry leaf material (0.5 g) was ground to a fine 147 
powder using a TissueLyser II ball mill fitted with stainless steel grinding jars (Qiagen, Crawley, 148 
UK) operated at 25 Hz for 1 min. Ten mg sub-samples of dry leaf material were extracted in 9:1 149 
(v/v) chloroform:ethanol with gentle shaking for 1 h and then analysed as per fresh material.  150 
For UPLC-MS analysis of sesquiterpenes, a diluted (1:5 (v/v) extract:ethanol) 2 µL aliquot was 151 
LQMHFWHGRQDQ$FTXLW\83/&V\VWHP:DWHUV(OVWUHH8.ILWWHGZLWKD/XQDîPPȝP152 
HST column (Phenomenex, Macclesfield, UK). Metabolites were eluted at 0.6 mL/min and 60°C 153 
using a linear gradient from 60% to 100% A:B over 2.5 min, where A = 5% (v/v) aqueous 154 
MeOH and B = MeOH, with both A and B containing 0.1% (v/v) formic acid. Pseudomolecular 155 
[M+H]+ ions were detected using a Thermo Fisher LTQ-Orbitrap (ThermoFisher, Hemel 156 
Hempstead, UK) mass spectrometer fitted with an atmospheric pressure chemical ionization 157 
source operating in positive ionisation mode under the control of Xcalibur 2.1 software. Data 158 
was acquired over the m/z range 100 - 1000 in FTMS centroid mode with resolution set to 7500 159 
FWHM at m/z 400. Data extraction and analysis was performed using packages and custom 160 
scripts in R 3.2.2 ( https://www.R-project.org/). XCMS (Smith et al., 2006) incorporating the 161 
centWave algorithm (Tautenhahn et al., 2008) was used for untargeted peak extraction. 162 
Deisotoping, fragment and adduct removal was performed using CAMERA (Kuhl et al., 2012). 163 
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Artemisinin was quantified using the standard curve of the response ratio of artemisinin (Sigma, 164 
Poole, UK) WRLQWHUQDOVWDQGDUGȕ-artemether; Hallochem Pharmaceutical, Hong Kong) that was 165 
previously added to extracts and standards. Metabolites were identified with reference to 166 
authentic standards or NMR-resolved structures and empirical mass formulae calculated using 167 
the R package rcdk (Guha, 2007) within 10 ppm error and elemental constraints of: C = 1±100, 168 
H = 1-200, O = 0±20, N = 0 ± 1. Peak concentrations were calculated using bracketed response 169 
curves, where standard curves were run every ~30 samples. Metabolite concentrations were 170 
expressed as a proportion of the residual dry leaf material following extraction.  171 
For analysis of monoterpenes and volatile sesquiterpenes from fresh leaf samples, an aliquot of 172 
chloroform extract (prior to dilution with ethanol for UPLC analysis) was taken for GC-MS 173 
analysis using an Agilent 6890 GC interfaced to a Leco Pegasus IV TOF MS (Leco, Stockport, 174 
UK). A 1 µL aliquot was injected into a CIS4 injector (Gerstel, Mülheim an der Ruhr, Germany) 175 
fitted with a 2 mm ID glass liner containing deactivated glass wool at 10°C. The injector was 176 
ramped from 10°C to 300°C at 12°C/s then held at 300°C for 5 min. The carrier gas was He at a 177 
constant flow of 1 mL/min and the injection split ratio was 1:10. Peaks were eluted using a 178 
Restek Rxi-5Sil MS column, 30 m x 0.25 mm ID x 0.25 µm film thickness (Thames Restek, 179 
Saunderton, UK). The following temperature gradient was used: isothermal 40°C 2 min; ramp at 180 
20°C/min to 320°C then hold for 1 min; total run time ~20 min.  The transfer line was 181 
maintained at 250°C and the MS used to collect -70 eV EI scans over the m/z range 20-450 at a 182 
scan rate of 20 spectra/second. Acquisition was controlled by ChromaTof 4.5 software (Leco). 183 
ChromaTof was used to identify peaks and deconvolute spectra from each run, assuming a peak 184 
width of 3 s and a minimum s/n of 10. Peak areas were reported as deconvoluted total ion traces 185 
(DTIC). Further analyses including annotation against authentic standards, between-sample peak 186 
alignment, grouping, consensus DTIC reporting, and missing value imputation were performed 187 
using custom scripts in R.  188 
 R was used for all statistical data analysis using the stats base package, nlme (http://CRAN.R-189 
project.org/package=nlme) and pcaMethods (Stacklies et al., 2007) 190 
2.6 RNA isolation, cDNA synthesis and quantitative RT-PCR 191 
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Leaf tissue from juvenile and mature-stage leaves sampled as described above was ground to a 192 
fine powder using Qiagen Retsch MM300 TissueLyser (Qiagen, Hilden, Germany) and total 193 
RNA extracted using the RNAeasy kit (Qiagen, Hilden, Germany). RNA was quantified using 194 
NanoDrop-1000 (NanoDrop products, Wilmington, USA) and integrity was checked on 2200 195 
Tape Station Instrument (Agilent, Santa Clara, CA, USA). Only samples scoring RIN number 196 
ZHUHWDNHQIRr further analysis. Removal of genomic DNA was performed by treating with 197 
TURBO DNA-IUHH /LIH 7HFKQRORJLHV /WG 3DLVOH\ 8. IROORZLQJ PDQXIDFWXUHU
V198 
instructions. 5 ug of total RNA, pooled from 4 individual plants, representing 3 biological 199 
replicates, was reversely transcribed using SuperScript II kit (Life Technologies Ltd, Paisley, 200 
UK) and Oligo(dT)12-18 Primer (Life Technologies Ltd, Paisley , UK) according to 201 
manufacturer's instructions. PCR using primers (AMS_Ex4 fRU ¶-202 
GGCTGTCTCTGCACCTCCTC-¶ $06_Ex5 fRU ¶- CAGCCATCAATAACGGCCTTG -¶203 
designed spanning intron 4 of the AMS gene (GenBank: AF327527). Only samples that resulted 204 
in amplification of the 251bp fragment from cDNA and not the 363 bp fragment from genomic 205 
DNA were taken for further qPCR analysis.   206 
Expression levels of amorpha-4,11-diene synthase (AMS), amorpha-4,11-diene C-12 oxidase 207 
&<3$9 F\WRFKURPH 3 UHGXFWDVH &35 DUWHPLVLQLF DOGHK\GH ǻ   UHGXFWDVH208 
(DBR2) and aldehyde dehydrogenase (ALDH1), relative to ubiquitin (UBI) were determined by 209 
qPCR. Reactions were run in 3 technical replicates. Gene-specific primers used were: AMS for 210 
5'- GGGAGATCAGTTTCTCATCTATGAA- 3'; AMS_Rev 5'- 211 
CTTTTAGTAGTTGCCGCACTTCTT-
 ¶$/'+ fRU ¶- GATGTGTGTGGCAGGGTCTC-212 
¶ $/'+B5HY - ACGAGTGGCGAGATCAAAAG-¶ &<3$V1 fRU ¶- 213 
TCAACTGGAAACTCCCCAATG-¶ &<3$9B5HY ¶- CGGTCATGTCGATCTGGTCA-214 
¶ &35B)RU ¶- GCTCGGAACAGCCATCTTATTCTT-¶ &35B5HY ¶- 215 
GAAGCCTTCTGAGTCATCTTGTGT-¶'%5 fRU¶- GAACGGACGAATATGGTGGG-¶216 
'%5B5HY ¶- GCAGTATGAATTTGCAGCGGT-¶ UBI for 5'-217 
TGATTGGCGTCGTCTTCGA-3' and UBI_Rev 5'-CCCATCCTCCATTTCTAGCTCAT-3'. 218 
Reactions condtions and qPCR analysis were peformed as above, 1 ul of 1/20 first strand cDNA 219 
dilutiuon was used instead of genomic DNA. Background subtraction, average PCR efficiency 220 
for each amplicon and N0 values were calculated using LinRegPCR ver. 2012 software (Ruijter 221 
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et al 2009). Expression levels for each sample and gene of interest (GOI) were represented as N0 222 
GOI / N0 UBI. 223 
3 Results 224 
3.1 NMR spectroscopic analysis uncovers novel metabolites in both HAP and LAP 225 
chemotypes  226 
The natural products found in A. annua have previously been grouped into eight broad 227 
categories, including: i) monoterpenes; ii) sesquiterpenes; iii) diterpenes, iv) sterols and 228 
triterpenes; v) aliphatic hydrocarbons, alcohols, aldehydes and acids; vi) aromatic alcohols, 229 
ketones and acids; vi) phenylpropanoids; and viii) flavonoids (Brown, 2010). In the present work 230 
we have used the Artemis variety of A. annua as a representative of the HAP chemotype and 231 
NCV as a representative of the LAP chemotype (Larson et al., 2013). Our initial investigations 232 
using NMR analysis of leaf extracts of Artemis resulted in the isolation of 41 metabolites (6 of 233 
which were novel) representing all eight classes of natural products (Figure 1A, Supplemental 234 
List 1). The structures of all compoudns were determined by 1D- and 2D- NMR spectroscopy 235 
(detailed NMR data in Supplementary Section). Novel compounds which have not been isolated 236 
before as natural products include four new 11,13-dihydroamorphanes: ȕ-hydroperoxy-237 
eudesma-4(15),11-diene (4), 11-Hydroxy-arteannuin I (18),  6a-Hydroxy-arteannuin J (19) , 238 
Arteannuin P (20); the ketal form of arteannuin Q, (26) and abeo-Amorphane sesquiterpene (27). 239 
Artemisinin (22) was the most abundant metabolite in this analysis (Figure 2, Supplemental List 240 
1, and Supplemental Table 1); but the Artemis extract also contained two other sesquiterpenes: 241 
dihydroartemisinic acid (DHAA, 8), and dihydro-epi-deoxyarteannuin B (DHEDB, 12) in 242 
substantial amounts (Figure 2, Supplemental List 1 and Supplemental Table 1). In addition, a 243 
further nine known 11,13-dihydroamorphanes Į-epoxy-dihydroartemisinic acid (10) ĮĮ-244 
epoxy-Į-hydroxyamorphan-12-oic acid (11); dihydroarteannuin B (14); arteannuin M (15); 245 
arteannuins H, I and J (21, 16 and 17); deoxyartemisinin (23); and a 4,5-seco-4,5-diketo-246 
amorphan-12-oic acid (24) (see Figure 1A, Supplemental Figure 1 and Supplemental Table 1) 247 
were also isolated as minor components from the Artemis leaf extracts (Figure 2, Supplemental 248 
List 1 and Supplemental Table 1) 249 
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Phytochemical investigation of the NCV variety by NMR yielded 57 metabolites, 20 of which 250 
were novel (Figure 1B Supplemental List 2), representing 7 of the 8 categories above. Novel 251 
metabolites from NCV  variety are depicted on Figure 1B and include: (E)-7-Hydroxy-2,7-252 
dimethylocta-2,5-dien-4-one (43), (E)-7-Hydroperoxy-2,7-dimethylocta-2,5-dien-4-on (44), 6,7-253 
Epoxy-6,7-dihydro-ȕ-farnesene (45), 6-Hydroxy-Ȗ-humulene (48 Į-Hydroxy-artemisinic acid 254 
(52), Arteannuin R (54), Arteannuin S (55 Į Į-Epoxy-Į-hydroxyartemisinic acid methyl 255 
ester (57), Dehydroarteannuin L (59), epi-11-Hydroxy-arteannuin I (64 $UWHPLVLQLF DFLG Į-256 
peroxy ester (65), Deoxyartemistene (67) (novel as a natural product1), Arteannuin T (69), 257 
Arteannuin U (70), Arteannuin V (72), Arteannuin W (73), Arteannuin Y (74), Isoarteannuin A 258 
(77), Arteannuin Z (78) and 3-(2-(2,5-Dihydrofuran-3-yl)ethyl)-2,2-dimethyl-4-259 
methylenecyclohexan-1-one (79).  260 
As might have been expected, the most striking difference between the NCV and Artemis 261 
varieties was the almost complete absence of artemisinin, DHAA (8) and DHEDB (12) in the 262 
former (Supplemental Table 1). The NCV variety did, however, have relatively high levels of 263 
three 11-13-unsaturated amorphanes, which were found only as minor components in the 264 
Artemis variety, namely: artemisinic acid (AA, 9), arteannuin B (ArtB, 60) and epi-265 
deoxyarteannuin B (EDB, 13) (Figure 2, Supplemental Figure 2 and Supplemental Table 1). All 266 
the other amorphane sesquiterpenes isolated and characterized from the NCV variety by NMR 267 
shared this same trait: i.e. possession of an 11,13-unsaturated methylene group (Figure 1B, 268 
Figure 2 and Supplemental Table 1), and there is an almost complete absence of 11,13-dihydro-269 
amorphanes from NCV, that contrasts with the abundance of these compounds in the Artemis 270 
variety (Supplemental List 2 and Supplemental Table 1). It is interesting to note that there are ten 271 
examples where 11,13-dihdyro/ 11,13-dehydro amorphanolides seem to occur DV³SDLUV´EHWZHHQ 272 
Artemis and NCV depicted on Figure 2. These include: DHAA (8) / AA (9); artemisinin (22) / 273 
artemisitene (65); dihydro-epi-deoxyarteannuin B (12) / epi-deoxyarteannuin B (13) Į-epoxy-274 
dihydroartemisinic acid (10)  Į-epoxy-artemisinic acid (56); dihydroarteannuin B (14) / 275 
arteannuin B (60); arteannuin M (15) / dehydroarteannuin M (61); arteannuin I (16) / annulide 276 
(62); arteannuin J (17) / isoannulide (63); deoxyartemsinin (23) / deoxyartemsitene (67); and 4,5-277 
seco-4,5-diketo-amorphan-12-oic acid (24) and its 11,13-dehydro-analogue (68). It is also 278 
noteworthy that 9 of the 20 novel amorphane and seco-amorphane sesquiterpenes isolated and 279 
characterized from the NCV variety by NMR, possess an 11, 13-unsaturated methylene group 280 
(Figure 1B, Supplemental List 2) 281 
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All the above results are consistent with a higher DBR2 activity in the HAP chemotype 282 
compared to LAP chemotype (Yang et al., 2015). The relative abundances for 8 of these 10 283 
³SDLUV´ are also well matched between the Artemis and NCV YDULHWLHV VXJJHVWLQJ D ³VKDUHG´284 
further metabolism for DHAA in Artemis and AA in NCV. The first exception is arteannuin B 285 
(ArtB 60), which is abundant in NCV, whilst its analogue, dihydroarteannuin B (14), is relatively 286 
low in Artemis. (Supplemental Table 1). The second is artemisitene, the 11,13-dehydro analogue 287 
of artemisinin (Acton et al., 1985; (Woerdenbag et al., 1994) (Fig 1; Supplemental Table 1) 288 
which is a minor compound in NCV, ZKLOH LWV µSDUWQHU¶ artemisinin is the most abundant 289 
metabolite in Artemis (Supplemental Table 1). These observations suggest that while there are 290 
many parallels in the pathways that further transform DHAA (8) and AA (9) in the HAP and 291 
LAP chemotypes there are some significant differences. 292 
3.2 Metabolomic and gene expression studies reveal multiple differences between HAP and 293 
LAP chemotypes.  294 
Using a leaf maturation time-series, we recently demonstrated that artemisinin levels increase 295 
gradually from juvenile to mature leaves and remain stable during the post-harvest drying 296 
process in Artemis HAP chemotype plants (Czechowski et al., 2016). Using a similar time-series 297 
(which included fresh leaf 1±5 (juvenile), and 11±13 (mature) (counting from the apical 298 
meristem); plus oven-dried whole plant-stripped leaves (dry) from 12-week-old glasshouse-299 
grown plants), we have now performed UPLC- and GC-MS based metabolite profiling of 300 
extracts from both HAP (Artemis) and LAP (NCV) chemotypes. We found that the pathway 301 
entry±point metabolite, amorpha-4,11-diene (A-4,11-D), is only detectable in juvenile leaves, 302 
and at approximately 2-fold higher concentration in Artemis as compared to NCV (Figure 3Ai; 303 
Supplemental Table 3). A much greater difference was seen for the enzymatically-produced 304 
artemisinin precursor, dihydroartemisinic acid (DHAA), which was present at a 24-fold higher 305 
concentration in juvenile Artemis leaves compared to NCV (Figure 3A ii), Supplemental Table 306 
2). Artemisinic acid (AA) on the other hand accumulated in NCV leaves at a 10-fold higher 307 
concentration than in Artemis (Figure 3A iii), Supplemental Table 1). Interestingly the levels of 308 
AA in the young leaves of NCV variety are approximately twice the levels of DHAA in young 309 
leaves of Artemis (Figure 3A ii) and iii), Supplemental Table 2). The levels of both DHAA and 310 
AA dropped sharply beyond the juvenile leaf stage in Artemis and NCV, respectively (Figure 3A 311 
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ii) and iii), Supplemental Table 2). These changes in metabolite levels occur during leaf 312 
maturation are mirrored by changes in steady state mRNA levels of genes encoding the enzymes 313 
involved in their biosynthesis including: amorpha-4,11-diene synthase (AMS), amorpha-4,11-314 
diene C-R[LGDVH&<3$9DUWHPLVLQLFDOGHK\GHǻ11,(13) reductase (DBR2) and aldehyde 315 
dehydrogenase (ALDH1) which are expressed at levels two to three orders of magnitude higher 316 
in juvenile than in mature leaves (Figure 3B i), ii), iii), iv)).  317 
Previous work has suggested that in vivo conversions beyond DHAA (8) (Czechowski et al., 318 
2016) and in vitro conversions beyond AA (9) (Brown and Sy, 2007) are non-enzymatic. 319 
Consistent with this, we have found that mature leaves of NCV contain high levels of epi-320 
deoxyarteannuin B (EDB, 13) and arteannuin B (ArtB, 60) and (Figure 3A v) and vii), 321 
Supplemental Table 2), while Artemis accumulates dihydro-epi-deoxyarteannuin B (DHEDB, 322 
12) and artemisinin (22) (Figure 3A iv), vi) Supplemental Table 2) at 20 to 30-fold higher levels 323 
than NCV. Both artemisinin (22) and arteannuin B (60) continue to accumulate in the post-324 
harvest drying process in Artemis and NCV respectively (Figure 3A vi) and vii)). Post-harvest 325 
accumulation of artemisinin has been reported before (Ferreira and Luthria, 2010) Iand it might 326 
be related to light-dependent conversion of DHAA. However  slightly different batch specific 327 
environmental effects during drying might explain difference between artemisinin accumulation 328 
pattern shown on Figure 3A vi) and what was previously reported for the Artemis variety 329 
(Czechowski et al., 2016). Interestingly, the developmental pattern of DHEDB (12) 330 
accumulation in Artemis leaves is different to its 11,13-dehydro analog, EDB (13) in NCV 331 
leaves. DHEDB (12) follws the same accumulation pattern as for artemsinin (22) in Artemis 332 
(Figure 3A iv) and vi)); whereas EDB (13) is found predominantly in juvenile leaves of the NCV 333 
variety (Figure 3A v)). We have found that production of the artemisinin 11,13-dehydro analog, 334 
artemisitene (66) in NCV parallels the accumulation of artemisinin (22) in Artemis 335 
(Supplemental Table 2), albeit at very much reduced levels. The levels of deoxyartemisinin (23), 336 
another product of non-enzymatic conversion of DHAA through the DHAA allylic 337 
hydroperoxide, increase during dry leaf storage, accumulating to 0.1% leaf dry weight 338 
(Supplemental Table 2), which is consistent with previous findings (Czechowski et al., 2016). 339 
This process is paralleled by accumulation of deoxyartemisitene (67) (the 11,13-dehydro analog 340 
of deoxyartemisinin) in the NCV variety (Supplemental Table 2).  341 
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RT-qPCR analysis confirmed the expression level for DBR2 to be significantly repressed (8-fold 342 
lower) in the juvenile leaves of NCV compared to Artemis, which is consistent with previous 343 
findings (Yang et al. 2015). Interestingly, DBR2 transcript abundance had decreased to the same 344 
levels in mature leaves of both chemotypes (Figure 3B iii)), highlighting the importance of 345 
developmental timing in regulating flux and partitioning of sesquiterpene metabolites. More 346 
surprisingly, ALDH1 expression is increased in juvenile leaves (2.4-fold) and further increased in 347 
mature leaves (40-fold) of NCV (Figure 3B iv)) compared to Artemis. Thus it would appear that 348 
in addition to DBR2 being down-regulated in the NCV (LAP) chemotype, ALDH1 is up-349 
regulated at the transcriptional level. This could also account for the increase in flux into 350 
artemisinic acid and the artemisitene branch of sesquiterpene metabolism. The major differences 351 
in metabolite levels and gene expression between Artemis and NCV varieties for the artemisinin 352 
biosynthetic pathway are summarized in Figure 3C. 353 
NMR analysis revealed that metabolite differences between Artemis and NCV are not restricted 354 
to artemisinin-related sesquiterpenes. Monoterpenes also vary between the two chemotypes, with 355 
for example camphor being most abundant in Artemis while artemisia ketone level is much more 356 
abundant in NCV (Supplemental Table 1). Unfortunately, NMR-analysis could only provide 357 
approximate information about the relative abundance of the metabolites, therefore metabolite 358 
content of both chemotypes was also studied by GC- and UPLC-MS (Supplemental Tables 2 and 359 
3). We were able to detect 75 unique compounds in three leaf types by UPLC-MS of which 360 
annotations were assigned to 30 compounds based on NMR-verified standards as described in 361 
the Materials and Methods. The majority of the known compounds were sesquiterpenes and 362 
flavonoids. GC-MS detected 202 unique compounds in juvenile and mature leaves, of which 33 363 
had assigned annotations. The majority of known GC-MS-detected compounds were mono- and 364 
sesquiterpenes. Using principal component analysis, it can be seen that the overall metabolite 365 
profile of NCV appears strikingly different to that of Artemis; as much as the difference between 366 
the profiles between juvenile leaves and mature- and/or dry leaves. In fact, UPLC- and GC-MS 367 
PCA plots show four distinct clusters (Figure 4A and B). Developmental differences are most 368 
apparent in juvenile leaf tissue, which show the highest abundance of most of the terpenes 369 
described below (Figure 4, Supplemental Tables 2 and 3). Our findings that the metabolite 370 
profiles in Artemis and NCV young leaf tissues are considerably different to mature and dry 371 
leaves in both varieties are consistent with our previous findings (Czechowski et al., 2016).  372 
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There are a number of compounds specifically produced by NCV, mostly in low quantities 373 
(Supplemental Tables 2 and 3) which have known medicinal use including, for example, 374 
isofraxidin (39), which is five-fold more abundant in the juvenile leaves of NCV as compared to 375 
Artemis (Supplemental Table 2). Isofraxidin is a coumarin with anti-inflammatory (Niu et al., 376 
2012) and anti-tumour activities (Yamazaki and Tokiwa, 2010). Artemisia ketone (42), an 377 
irregular monoterpene found in the essential oil from various A. annua varieties displaying 378 
antifungal activites (Santomauro et al., 2016) is the most abundant volatile in the juvenile and 379 
mature leaves of NCV, but virtually absent in Artemis (Supplemental Table 3). The juvenile and 380 
mature leaves of Artemis accumulate velleral, a sesquiterpene dialdehyde which has proposed 381 
antibacterial activities (Anke and Sterner, 1991), which is virtually absent in NCV variety 382 
(Supplemental Table 3). GC-MS analysis further revealed that several major montoerpenes are 383 
also more abundant in juvenile and mature leaves of Artemis, including camphor (3.7-fold 384 
higher), camphene (3.4-fold higher), borneol, (16-IROG KLJKHU Į-pinene (4.6-fold higher) and 385 
1,8-cineole (8-fold higher) (Supplemental Table 3). Some minor monoterpenes detected in the 386 
Artemis variety, such as: Į-P\UFHQHĮ±terpinene, chrysanthenone and Į-copaene, are virtually 387 
absent in young and mature NCV leaves (Supplemental Table 3). A few striking differences 388 
were noted for the level of artemisinin-unrelated abundant sesquiterpenes, such as sabinene and 389 
cis-sabinene hydrate, which are 7.5-fold and 38-fold (respectively) more abundant in Artemis 390 
young leaves than in NCV (Supplemental Table 3). Germacrene A is a sesquiterpene common 391 
across the Asteraceae family for which it has been demonstrated that its downstream metabolism 392 
parallels artemisinic acid biosynthetic pathway (Nguyen et al., 2010) . Germacrene A levels are 393 
32- and 17-fold higher in NCV young and mature leaves (respectively) making it the most 394 
abundant volatile in mature and the second most abundant in young leaves of the NCV variety.  395 
Visualisation of the loadings from the multivariate analyses were used to identify the most 396 
influential compounds discriminating chemotypes. PC1 loading plots identified 18 compounds 397 
from UPLC- and 20 from GC-MS analysis (Supplemental Figure 1), which were used to create 398 
the heatmaps presented in Figure 5. The vast majority of the most influential compounds 399 
distinguishing between two chemotypes from UPLC-MS analysis were the amorphane 400 
sesquiterpenes (Figure  5A). The mono- and sesquiterpenes mentioned above (together with 401 
some unknown compounds) were the most influential GC-MS-detectable metabolites 402 
distinguishing between two chemotypes (Figure 5B).   403 
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3.3 Morphological difference between two chemotypes of A. annua  404 
In addition to having very distinct phytochemical compositions the F1 Artemis HAP chemotype 405 
and the open pollinated NCV LAP chemotype varieties also have very distinct morphological 406 
features (Figure 6). Most strikingly, NCV is much taller with longer internodes but produces 407 
smaller leaves than Artemis. The density of glandular secretory trichomes, the site of artemisinin 408 
synthesis, is similar for both varieties (Figure 6 E), which is consistent with the main difference 409 
in artemisinin production is due to an alteration in metabolism rather than trichome density. A. 410 
annua varieties typically require short day length for flowering (Wetzstein et al., 2014), but we 411 
observed that NCV, unlike Artemis, can also flower under long days. However, the two 412 
chemotypes do cross-pollinate and produce viable progeny. 413 
4 Discussion 414 
This manuscript presents the first detailed phytochemical comparison of high- (HAP) and low-415 
artemisinin production (LAP) chemotypes of A. annua.  416 
26 of the 85 metabolites that have been characterized by NMR from the HAP and LAP varieties 417 
of A. annua in this study are novel as natural products (all are mono- and sesquiterpenes). And of 418 
these, 19 are amorphane sesquiterpenes, which is the most diverse and the most abundant sub- 419 
class (Supplementary Table 1, Supplementary Lists 1 and 2). The majority of these amorphane 420 
sesquiterpenes are highly oxygenated with structures that would be consistent with further 421 
oxidative metabolism of DHAA (11,13-saturated, 8) in the HAP variety and AA (11,13-422 
unsaturated, 9) in the LAP variety (Figure 1, Figure 2, Supplementary Table 1, Supplemental 423 
Lists 1 and 2) 424 
UPLC- and GC-MS analysis of leaf developmental series also revealed amorphanes either 425 
saturated or unsaturated at the 11,13-position in the HAP and LAP chemotypes, respectively 426 
(Figure 3, Supplemental Table 2). This observation is consistent with the expression of the DBR2 427 
gene, which encodes the enzyme responsible for reducing the 11,13-double bond of artemisinic 428 
aldehyde (the precursor for 11,13-dihydroamorphane/cadinane sesquiterpenes) being strongly 429 
down-regulated in juvenile leaves of NCV (Figure 3B iii). These findings are in complete 430 
agreement with the recent report on reduced levels of DBR2 in LAP compared with HAP 431 
chemotypes (Yang et al., 2015). In addition to altered expression of DBR2, we also found that 432 
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expression of aldehyde dehydrogenase (ALDH1), which converts artemsinic and 433 
dihydroartemsinic aldehydes to acids (Teoh et al., 2009), is significantly elevated in juvenile and 434 
mature leaves of NCV compared to Artemis. This may lead to an increased flux from A-4,11-D 435 
to AA in NCV when compared with flux from A-4,11-D to DHAA in Artemis which is reflected 436 
by significantly higher concentration of AA found in juvenile leafs of NCV when compared to 437 
concentration of DHAA in Artemis young leaves (Figure 3A iii) and ii). could enable increased 438 
flux from artemisinic aldehyde to artemisinic acid which we have observed in young leaves of 439 
NCV variety (Figure 3B iv). The elevated flux from A-4,11-D to AA might also explain lower 440 
levels of A-4,11-D found in juvenile leaves of NCV when compared with Artemis (Figure 3A i) 441 
as the expression of amorpha-4,11-diene synthase (AMS) is at very similar level in both varieties 442 
(Figure 3B i).  We have also observed that the NCV (LAP) variety expresses a sequence variant 443 
of amorpha-4,11-diene C-12 oxidase (CYP71AV1) with a 7 amino acid N-extension 444 
(Supplemental Figure 2). This LAP-chemotype associated is sequence variant was previously 445 
shown variant upon transient expression in Nicotiana benthamiana, in combination with the 446 
other artemisinin pathway genes resulted (Ting et al., 2013a)in a qualitatively different product 447 
SURILOH µFKHPRW\SH¶ WKDW LV , in a shift in the ratio between the unsaturated and saturated 448 
(dihydro) branch of the pathway (Ting et al., 2013a). That result strongly suggests the two 449 
distinct isoforms of CYP71AV1 are associated with HAP- and LAP-branches of the artemisinin 450 
pathway also in Artemsia annua (Figure 3 C). to be more efficient in the conversion of amorpha-451 
4,11-diene to artemisinic acid (AA) than to artemisinic aldehyde (AAA) (Ting et al., 2013b). 452 
Thus in NCV we find decreased expression of DBR2, increased expression of ALDH1 and the 453 
presence of a sequence variant of CYP71AV1 that favours conversion of AAA to AA. We 454 
propose that these factors (Ting et al., 2013a)together lead to an increased flux from A-4,11-D to 455 
AA in NCV when compared with flux from A-4,11-D to DHAA in Artemis which is reflected by 456 
significantly higher concentration of AA found in juvenile leafs of NCV when compared to 457 
concentration of DHAA in Artemis young leaves (Figure 3A iii) and ii). The elevated flux from 458 
A-4,11-D to AA might also explain lower levels of A-4,11-D found in juvenile leaves of NCV 459 
when compared with Artemis (Figure 3A i) as the expression of amorpha-4,11-diene synthase 460 
(AMS) is at very similar level in both varieties (Figure 3B i). A number of previous reports 461 
described the existence of LAP- and HAP-chemotypes of A. annua arising from distinct 462 
geographical locations (Lommen et al., 2006); (Arsenault et al., 2010), (Larson et al., 2013). It 463 
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would be interesting to establish if sequence variant forms of CYP71AV1 and differential 464 
expression of DBR2 are generally found between these other LAP- and HAP-chemotypes. 465 
Recent attempts to constitutively overexpress DBR2 in transgenic A. annua resulted in doubling 466 
of the artemisinin concentration, which was also accompanied by a significant increase in DHAA 467 
and AA production (Yuan et al., 2015). Improvements in artemisinin concentration obtained in 468 
these experiments by Yuan et al. were significantly better than those achieved by constitutive co-469 
expression of CYP71AV1 and CPR (Shen et al., 2012), where the LAP-sequence variant of 470 
CYP71AV1 was overexpressed in transgenic A. annua. Our results suggest the glandular 471 
trichome-targeted overexpression of DBR2 specifically in the HAP-type of CYP71AV1 might be 472 
the more efficient route to improving artemisinin production in transgenic A. annua  473 
Although arteannuin B (ArtB) was almost entirely absent from young leaf tissue of the NCV 474 
variety, as leaves matured it accumulated to become the most abundant natural product (Figure 475 
3A vii). This first observation seemed to parallel both the accumulation of artemisinin in the 476 
mature tissues of Artemis that has been noted above (Figure 3vi), as well as the recently 477 
described accumulation of arteannuin X in the mature leaves of the cyp71av1-1 mutant of A. 478 
annua (Czechowski et al., 2016). The accumulation of both artemisinin and arteannuin X are 479 
considered to be the result of non-enzymatic processes, in which the 4,5-double bond of a 480 
precursor sesquiterpene undergoes spontaneous autoxidation with molecular oxygen to produce a 481 
tertiary allylic hydroperoxide. The metabolic fate of this hydroperoxide is critically dependant on 482 
the identity of the precursor ± and in particular on the functionality contained elsewhere in the 483 
molecule. Thus, in the case of Artemis, the precursor is DHAA which presents a 12-carboxylic 484 
acid group (as well as saturation at the 11,13-position); whilst for the cyp71av1-1 mutant it is 485 
amorpha-4,11-diene (A-4,11-D), which presents a 11,13-double bond (Czechowski et al., 2016). 486 
Both in vivo and in vitro experiments indicate that this difference in functionality is the basis 487 
why DHAA-OOH (the tertiary allylic hydroperoxide from DHAA) is converted to artemisinin, 488 
whereas A-4,11-D-OOH is converted to arteannuin X (Czechowski et al., 2016). 489 
We therefore hypothesised that the conversion of artemisinic acid (AA) to artemisitene (Art B) in 490 
NCV may also be a non-enzymatic process, paralleling the conversion of DHAA into artemisinin 491 
in Artemis (Supplemental figure 3A and B) and of amorpha-4,11-diene to arteannuin X in the 492 
cyp71av1-1 mutant (Czechowski et al., 2016). The tertiary allylic hydroperoxide from 493 
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artemisinic acid (AA-OOH) differs from the two foregoing examples in that it incorporates both 494 
a 12-carboxylic acid group and unsaturation at the 11,13-position. In support of this hypothesis, 495 
when a sample of AA-OOH (produced by photosensitized oxygenation of AA; and purified by 496 
HPLC) was left unattended for several weeks, it was indeed found to have been converted 497 
predominantly to ArtB (albeit at a rate that was significantly slower than for the conversion of 498 
DHAA-OOH to artemisinin). This unexpected transformation is mostly simply explained by 499 
attack of the 12-carboxylic acid group at the allylic position of the hydroperoxide, as is shown in 500 
Supplemental figure 3A and B. Further studies will be required to explain why it should be that 501 
this (apparently) rather subtle modification to the 12-CO2H group (i.e. the introduction of 11,13-502 
unsaturation in AA-OOH) has resulted in such a radically different pathway, as compared with 503 
DHAA-OOH.  504 
The second most abundant product of AA-OOH conversion is Epi-deoxyarteannuin B (EDB), 505 
which accumulates predominantly in young leaves of NCV. The EDB accumulation pattern is 506 
therefore different to DHEDB (the 11,13-saturated anaologue), ZKHUHWKH ODWWHU¶VFRQFHQWUDWLRQ507 
rises from top to mature and dry leaves in Artemis, broadly following the accumulation pattern 508 
of artemisinin. We have proposed that the spontaneous conversions of AA into EDB and DHAA 509 
into DHEDB progress via very similar molecular mechanisms (Supplemental figure 3C and D). 510 
Interestingly we have observed very little EDB arising from the spontaneous conversions of AA-511 
OOH described above, which was predominantly converted to ArtB. It is known that a 512 
hydrophobic (lipophilic) environment promotes conversions of DHAA-OOH into artemisinin 513 
whereas an aqueous, acidic medium promotes DHAA-OOH conversions to DHEDB (Brown and 514 
Sy, 2004). This may also explain the very minor conversion of AA-OOH into EDB which was 515 
carried out in a hydrophobic environment (deuterated chloroform), and which promoted AA-516 
OOH conversions to ArtB. This highlights the parallels between artemisinin and arteannuin B 517 
biogenesis shown in Supplemental figure 3A and B. It also suggests that in vivo conversions of 518 
AA-OOH to EDB requires an aqueous intra-cellular environment, which might be expected to be 519 
present in young leaf trichomes, but less so in mature leaf trichomes where the sub-apical 520 
hydrophobic cavities are predominant (Ferreira and Janick, 1995), or upon cell dehydration (in 521 
dried leaf material).  522 
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Differences between the LAP and HAP chemotypes extended well beyond artemisinin-related 523 
sequiterpenes to other classes of terpenes (Figure 4, 5, Supplemental Tables 1, 2 and 3). This 524 
divergence at the level of metabolism is not that surprising given that these chemotypes also 525 
exhibit significant differences in their morphology (Figure 5). Artemis is an F1 hybrid derived 526 
from HAP parents of East Asian origin (Delabays et al., 2001) while NCV is an open-pollinated 527 
variety of Europe origin (personal communication with Dr. Michael Schwerdtfeger, curator of 528 
Botanical Garden at the University of Göttingen, Germany). This is consistent with the general 529 
trend for the A. annua varieties of European and North American which mostly represent the 530 
LAP chemotype and the majority of East-Asian origin varieties which represent the HAP 531 
chemotype (Wallart et al., 2000), Details of the genetic divergence of these varieties remains a 532 
topic for further investigation that could reveal further insight into the sesquiterpene flux into 533 
different end products.  534 
5 Conclusion  535 
This first comparative phytochemical analysis of high- (HAP) and low-artemisinin production 536 
(LAP) chemotypes of A. annua resulted in the characterisation of over 84 natural products by 537 
NMR, 26 of which have not previously been described in A. annua. We have also shown that the 538 
vast majority of amorphane sesquiterpenes are unsaturated at the 11,13-position in LAP-539 
chemotype as opposed to the majority of them being saturated at the 11,13-position in HAP-540 
chemotype. This is explained by existence of two sequence variants of CYP71AV1 in the two 541 
investigated chemotypes and differential expression of the key branching enzyme in artemisinin 542 
pathway, namely DUWHPLVLQLF DOGHK\GH ǻ   UHGXFWDVH '%5. By highlighting the main 543 
points of difference between HAP and LAP chemotypes our findings will help inform strategies 544 
for the future improvement of artemisinin production in either A. annua or heterologous hosts. 545 
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Figure legends: 709 
Figure 1. Novel natural compounds characterised from the Artemis (A) and NCV (B) 710 
varieties of A. annua by NMR approach.  711 
Numbering of compounds is consistent with Supplemental Lists 1 and 2. Numbering of carbon 712 
atoms showed.   713 
Figure 2. Ten pairs of 11,13-dihdyro/ 11,13-dehydro amorphanolides between Artemis 714 
(left-hand side) and NCV (right-hand side) varieties of A. annua characterised by the NMR 715 
approach. 716 
Numbering of compounds is consistent with Supplemental Lists 1 and 2. Numbering of carbon 717 
atoms showed. Novel compound indicated by asterisk  718 
Figure 3. Metabolic and transcriptomic comparison of the artemisinin pathway in the low- 719 
versus high-artemisinin chemotypes of A. annua 720 
A) Level of selected sesquiterpenes were quantified by GC-MS (i) and UPLC-MS (ii)-(vii) in 721 
fresh juvenile leaf 1-5 (Top), fresh mature leaf 11-13 (Mid.) and oven-dried whole plant-stripped 722 
leaves (Dry) from 12-weeks old glasshouse-grown Artemis (green bars) and NCV (grey bars) 723 
varieties as described in Materials and methods. SI; error bars ± SEM (n=15 for Top and Mid. 724 
leaf; n=6 for Dry OHDI /HWWHUV UHSUHVHQW 7XNH\¶V UDQJH WHVW UHVXOWV DIWHURQH ZD\ $129$ RU725 
REML (see Materials and Methods for details). Groups not sharing letters indicate statistically 726 
significant differences. (B) ± Transcript profiling of enzymes involved in the artemisinin 727 
biosynthetic pathway, in two types of leaf material as on panel (A) was done as described in 728 
materials and methods, error bars ± SE (n=9). Asterisk indicates t-test statically significant 729 
difference between Artemis (green bars) and NCV (grey bars) at p<0.05. (C) Summary of the 730 
metabolite and transcriptional differences between Artemis and NCV for the artemisinin 731 
biosynthetic pathway: full arrows ± known enzymatic steps, dashed arrows ± non-enzymatic 732 
conversions, red arrows ± transcript changes in juvenile leaves of NCV vs. Artemis, green 733 
arrows ± metabolite changes of NCV vs. Artemis (all types of leaves). DBR2 position in the 734 
pathway highlighted in a square.   735 
Metabolite abbreviations: G-3-P ± glyceraldehyde-3-phosphate; MEP - 2-C-methylerythritol 4-736 
phosphate; MEcPP - 2-C-methyl-D-erythritol-2,4-cyclopyrophosphate. Cytosolic precursors: 737 
HMG-CoA - 3-hydroxy-3-methylglutaryl-CoA; MVA ± mevalonate; IPP ± isopentenyl 738 
pyrophosphate; DMAPP ± dimethylallyl pyrophosphate; FPP ± farnesyl pyrophosphate; A-4,11-739 
D ± amorpha-4,11-diene; AAOH ± artemsinic alcohol; AAA ± artemsinic aldehyde; AA ± 740 
artemsinic acid; ArtB ± arteannuin B; DHAAA - dihydroartemsinic aldehyde; DHAA - 741 
dihydroartemsinic acid; DHAAOOH- dihydroartemsinic acid tertiary hydroperoxide; DHEDB ± 742 
dihydro-epi-deoxyarteanniun B. AAOOH - artemsinic acid tertiary hydroperoxide, EDB ± epi-743 
deoxyarteannuin B. Enzyme abbreviations: HMGR- 3-hydroxy-3-methylglutaryl coenzyme A 744 
reductase, HDR- 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, DXR - 1-deoxy-D-745 
xylulose-5-phosphate reductoisomerase, DXS- 1-deoxy-D-xylulose-5-phosphate synthase, FPS - 746 
farnesyl diphosphate synthase. AMS ± amorpha-4,11-diene synthase, CYP71AV1 - amorpha-747 
4,11-diene C-12 oxidase, CPR ± cytochrome P450 reductase, DBR2 - DUWHPLVLQLFDOGHK\GHǻ748 
(13) reductase, ALDH1 - aldehyde dehydrogenase.  749 
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Figure 4. Principal component analysis of UPLC-MS (A) and GC-MS (B) data from 750 
different leaf types from Artemis and NCV varieties. 751 
 Principal component analysis of 75 UPLC-MS identified peaks (A) and 202 GC-MS identified 752 
metabolites (B). Leaf types, corresponding with Figure 2 are represented by symbols: circles ± 753 
leaf 1-5, triangles ± leaf 11-13, crosshairs ± oven-dried leaf. Two chemotypes represented by 754 
colours green ± Artemis and grey ± NCV. PCA was performed on log-scaled data and mean-755 
FHQWUHGGDWDGRWWHGHOOLSVH +RWHOOLQJ¶VFRQILGHQFHLQWHUYDO 756 
Figure 5. Heatmaps of influential metabolites from UPLC- and GC-MS PCA analyses.  757 
Top-n (UPLC-MS = 18 (A); GC-MS = 20 (B)) metabolites were chosen for visualization based 758 
on loadings plots (Supplementary Fig 1Y) from the PC1 dimensions in the PCA analyses (Fig 759 
X). Mean data were log-scaled and then row-scaled for colour intensity plotting (lighter = more 760 
abundant). Hierarchical clustering was performed with average linkage, with Euclidean distances 761 
for genotypes and 1-absolute values of correlations as distances for metabolites.  Metabolite 762 
names are abbreviated where necessary for clarity and are given in full in Supplementary tables 2 763 
and 3.  764 
Figure 6. Morphological characterisation of low- and high-artemisinin natural chemotypes 765 
of A. annua 766 
(A) Photographs show four representative 12-week old plants from each two chemotypes of A. 767 
annua, ruler scaled in cm showed on both sides; Plant height (B), internode length (C), leaf area 768 
(D) and glandular secretory trichome density (E) recorded for 12-week old plants. Green bars 769 
represent Artemis (HAP-chemotype) and brown bars represent NCV (LAP-chemotype). Error 770 
bars ± SEM (n=15), letters represent one-way $129$7XNH\¶V UDQJH WHVW UHVXOWV Groups not 771 
sharing letters indicate statistically significant differences  772 
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